Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Coexistent Sickle Cell Disease has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke
Stroke 48:686-691, Adams, R.J.,et al, 2017
See this aricle in Pubmed

Article Abstract
Coexistent SCD had no significant impact on the safety or outcome of thrombolytic therapy in acute ischemic stroke. Although the sample size is relatively small, these data suggest that adults with SCD and acute ischemic stroke should be treated with thrombolysis, if they otherwise qualify. Addition studies, however, should track the intracranial hemorrhage rate and provide information on other SCD-related care such as transfusion.
 
Related Tags
(click to filter results - removes previous filter)

cerebrovascular accident
cerebrovascular accident,thrombolytic agents in treatment
efficacy
fibrinolytic agents
safety
sickle cell disease
tissue plasminogen activator,intravenous
treatment of neurologic disorder

Click Here to return To Results